The pharmaceutical industry has encountered previously unheard-of difficulties in recent years. The average cost of pharmaceuticals in the US has increased by 24% over the last three years as a result of safety concerns, problems with certain prescriptions, and competition from both non-generic and generic drugs. Prescription costs for those with private insurance decreased by 4% as a result between 2010 and 2013.Developing countries with similar challenges include Brazil, India, and China. Developing a series of vaccines with medicinal properties is one such treatment.Antibiotics are necessa